Search Results

AstraZeneca begins advanced trials for COVID-19 antibody medication

AstraZeneca begins advanced trials for COVID-19 antibody medication Monday, October 26, 2020 by: Ramon Tomey antibody medicine , antibody treatments , AstraZeneca , badhealth , badmedicine , Big Pharma , coronavirus antibodies , coronavirus vaccine , covid-19 , covid-19 pandemic , COVID-19 treatments , eli lilly , GlaxoSmithKline , long-acting antibodies , Pharmaceutical companies , polyclonal antibody cocktail , Regeneron , therapeutics , Wuhan coronavirus Bypass censorship by ...

First DEATH reported in AstraZeneca covid-19 vaccine trial, but human experimentation will continue anyway

Instead, AstraZeneca and Oxford University will continue their vaccine experiments unabated, with no formal questioning or investigation into their scientific method and toxic ingredients. ... AstraZeneca is one of four companies financed by United States taxpayers, as the federal government continues to push experimental biologics and mRNA inoculations into emergency authorization. "...

AstraZeneca ready to vaccinate half of Great Britain for coronavirus by SEPTEMBER

AstraZeneca ready to vaccinate half of Great Britain for coronavirus by SEPTEMBER Sunday, May 24, 2020 by: Ethan Huff 30 million doses , AstraZeneca , badhealth , badmedicine , coronavirus , covid-19 , Great Britain , Oxford , population , Public Health , safety testing , UK , United Kingdom , vaccinate , vaccines , Wuhan coronavirus - (Natural News ) Where will the first vaccines for the Wuhan coronavirus (COVID-19) be unleashed? ... “This deal with AstraZeneca means ...

COVID-19 vaccine trial participant DIES... AstraZeneca downplays the death and continues the medical experiments on the remaining humans

“It came after AstraZeneca said on Sept. 8 that its vaccine trial was placed on hold due to an illness in a patient in the United Kingdom,” reports TET. “The Food and Drug Administration placed a late-stage clinical trial from AstraZeneca on hold in the United States.” "...

Second AstraZeneca trial participant develops rare neurological condition following COVID-19 vaccination

Just like the first participant, who we reported developed severe spinal inflammation, this second one also manifested the exact same disease, which AstraZeneca claims is “rare” and unrelated to its clinical trials. ... Now, AstraZeneca will have to come up with another excuse for this second victim. "...

AstraZeneca deepens collaboration with academia - Buzz.NaturalNews.com

AstraZeneca deepens collaboration with academia Posted: October 30, 2012 | Comments Tweet Follow @HealthRanger (Reuters) - British academic researchers have secured 7 million pounds ($11 million) of funding from the country's Medical Research Council (MRC) to investigate a range of potential new drugs made available free-of-charge by AstraZeneca. ... Related Buzz Items - AstraZeneca sales hit hard by generic competition Have a Comment? "...

AstraZeneca tries to block generic drug approvals, gets slapped by court

AstraZeneca tries to block generic drug approvals, gets slapped by court Tuesday, July 17, 2012 by: J. ... Follow real-time breaking news headlines on AstraZeneca at FETCH.news The world of independent media, all in one place. - More news on AstraZeneca Did AstraZeneca fake clinical trial data for its ovarian cancer drug? "...

AstraZeneca Told Sales Reps to Lie About Seroquel-Diabetes Link

Drug giant AstraZeneca instructed its sales representatives to tell doctors that there was no link between its antipsychotic drug Seroquel and an increased risk of diabetes, even though studies conducted by the company had already shown otherwise, according to documents uncovered as part of a lawsuit. ... Follow real-time breaking news headlines on AstraZeneca at FETCH.news The world of independent media, all in one place. - More news on AstraZeneca Did AstraZeneca ...

Did AstraZeneca fake clinical trial data for its ovarian cancer drug?

AstraZeneca has come out making bold claims about their new experimental ovarian cancer drug called olaparib. "...

AstraZeneca sales hit hard by generic competition - Buzz.NaturalNews.com

AstraZeneca sales hit hard by generic competition Posted: July 26, 2012 | Comments Tweet Follow @HealthRanger (Reuters) - AstraZeneca's sales tumbled 21 percent in the second quarter, punished by generic competition to its best-selling antipsychotic medicine Seroquel and pressure on health spending in Europe. "...

AstraZeneca Denied Drug's Link to Diabetes for Years After Admitting Link to Japanese Physicians

Drug giant AstraZeneca attempted to obscure the connection between one of its blockbuster drugs and diabetes risk for years after it knew of the problem, according to documents recently unsealed as part of lawsuits against the company. ... Follow real-time breaking news headlines on AstraZeneca at FETCH.news The world of independent media, all in one place. - More news on AstraZeneca Did AstraZeneca fake clinical trial data for its ovarian cancer drug? "...

Secret Documents Reveal AstraZeneca Knowingly Promoted Psych Drugs for Unapproved Use in Children

Internal documents acquired as part of a series of lawsuits show that pharmaceutical giant AstraZeneca planned as early as 2001 to market its antipsychotic drug Seroquel for uses not approved by the FDA. ... AstraZeneca has applied for FDA approval to use Seroquel as a treatment for adolescent schizophrenia and acute bipolar mania in children and adolescents. "...

AstraZeneca Suppressed Information about Seroquel Link to Diabetes, Told Sales Reps to Lie

This fact was blatantly admitted in a 1999 e-mail sent by an AstraZeneca official. ... (http://online.wsj.com/article/SB123570604586... ) Today, AstraZeneca remains in spin control, once again apparently lying about its past behavior by saying, "None of the documents can obscure the fact that AstraZeneca acted responsibly and appropriately as it developed and marketed Seroquel." "...

AstraZeneca Suppressed Information about Seroquel Link to Diabetes, Told Sales Reps to Lie

This fact was blatantly admitted in a 1999 e-mail sent by an AstraZeneca official. ... (http://online.wsj.com/article/SB123570604586... ) Today, AstraZeneca remains in spin control, once again apparently lying about its past behavior by saying, "None of the documents can obscure the fact that AstraZeneca acted responsibly and appropriately as it developed and marketed Seroquel." "...

AstraZeneca’s no-profit pledge for coronavirus vaccines may end in 2021

It added that AstraZeneca would “seek expert guidance, including from global organizations” on when the pandemic has ended. ... In particular, the U.S. has supported AstraZeneca and other drugmakers under President Donald Trump’s Operation Warp Speed program. "...

AstraZeneca's COVID-19 vaccine trial halted following "serious adverse reaction" involving spinal inflammation

A frontrunner in the race to unveil a Wuhan coronavirus (COVID-19) vaccine, AstraZeneca issued a statement claiming that the trial’s suspension is “standard,” allowing for a “review of safety data.” ... So as not to scare the public into avoiding its vaccine once it gets publicly released, AstraZeneca claims that the trial could safely continue, but that it is currently on hold due to “an abundance of caution.” "...

"Serious adverse event" in AstraZeneca's COVID-19 vaccine trial revealed as spinal inflammation disorder caused by toxic adjuvants

This is actually the SECOND case of neurological damage caused by AstraZeneca’s COVID-19 vaccine At the same time, AstraZeneca has provided little in the way of actual evidence to show that actual progress is being made. ... This individual developed a similar neurological condition that was later dubbed as multiple sclerosis, with AstraZeneca insisting that it had absolutely nothing to do with the vaccine. "...

Myelitis observed in two COVID-19 vaccine trial participants is a common vaccine injury

AstraZeneca also disclosed – long after the fact – that the September break was actually the second time they had to stop their study. ... Of course, AstraZeneca only admitted this happened after the information was leaked by STAT . "...

Coronavirus vaccine trial participants harmed by the experimental drug will find it difficult to be compensated

Coronavirus vaccine trial participants harmed by the experimental drug will find it difficult to be compensated Monday, October 26, 2020 by: Arsenio Toledo AstraZeneca , badmedicine , Big Pharma , China , coronavirus , covid-19 , Flu , infections , Moderna , National vaccine Injury Compensation Program , outbreak , pandemic , side effects , superbugs , vaccine damage , vaccine injury , vaccine wars , vaccines , virus Bypass censorship by sharing this link: https://www.clearnewswire.com/465480....

Johnson & Johnson pauses coronavirus vaccine trial after participant contracts "unexplained illness"

(Related: Second AstraZeneca trial participant develops rare neurological condition following COVID-19 vaccination .) AstraZeneca has since resumed its trial with the University of Oxford in the U.K. but has yet to receive approval to do the same in the U.S. from the Food and Drug Administration (FDA). "...